NewslettersHuman Immunology News Interleukin-6 Blockade Abrogates Immunotherapy Toxicity and Promotes Tumor Immunity By Danielle Corrigan - May 9, 2022 0 Researchers performed a deep immune analysis of intestinal, colitis, and tumor tissue from immune checkpoint blockade-treated patients with parallel studies in preclinical models. [Cancer Cell] AbstractGraphical Abstract